Chonluten dosing & administration
Bronchopulmonary tripeptide bioregulator (Glu-Asp-Gly) that restores respiratory epithelial function through DNA minor groove binding at ATTTC sequences, induces TNF tolerance in alveolar macrophages reducing inflammatory cytokines by up to 6-fold, and normalizes bronchial mucosa differentiation markers in aging lung tissue
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Dosing
How much do I take?
Subcutaneous: A small injection into the fatty layer just under the skin — the same way insulin is given.
Bioavailability High — most of the dose reaches your bloodstream, just more gradually than an IV.
5-10 mg
Frequency
Once daily
Duration
10-20 days per course
For the synthetic peptide form, a dose commonly used in research practice given as an injection under the skin. [6]
Timing
Best time to take
Take Chonluten at the same time each day for consistent blood levels. Morning dosing with breakfast is often preferred, but follow your healthcare provider's specific instructions.
With food?
Chonluten can typically be taken with or without food. Taking it with a light meal may help reduce any GI discomfort. Avoid taking with grapefruit juice or high-fat meals unless specifically directed.
If stacking
Chonluten should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.
Adjusting your dose
Increase if
- You've tolerated the current dose for the recommended period without significant side effects
- Therapeutic goals haven't been met at the current dose level
- Your healthcare provider recommends dose escalation based on your response
- Lab work or clinical assessments support a higher dose
Decrease if
- Side effects are bothersome or impacting daily life despite management strategies
- You experience any signs of an adverse reaction
- Lab results indicate the need for dose reduction
- Your healthcare provider recommends a lower dose based on your response
Signs of right dose
- Therapeutic goals being met with minimal side effects
- Stable and consistent response to treatment
- Lab values or clinical markers trending in the right direction
- Good tolerance with manageable or absent side effects
Administration
How do I use it?
Reconstitution
What you need
Injection
Route
Chonluten is administered Sublingual (enteric-coated capsules)—no injection required
Best sites
Storage
Before reconstitution
Store Chonluten in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.
After reconstitution
Once reconstituted, Chonluten should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.
Signs of degradation — discard the vial
Sample daily schedule
As prescribed (once daily)
As prescribed by your healthcare provider injection
Site: Sublingual (enteric-coated capsules)—rotate sites if applicable
Maintain a consistent schedule for optimal results with Chonluten. Set reminders if needed. If you miss a dose, follow your healthcare provider's instructions—do not double up on doses to compensate.
Safety
Is it safe?
Side effects
Commonly reported: Injection site reaction, Mild fatigue, Transient respiratory changes, Mild headache
Less common: Flu-like symptoms
Stop and seek help if
- Severe or worsening side effects that don't improve with dose adjustment or supportive care
- Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
- Your healthcare provider recommends discontinuation based on your clinical response
- Development of any new medical condition that may be contraindicated with Chonluten
- Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
- Abnormal lab results or clinical markers that suggest adverse effects
Chonluten should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
Flagged pairings
- Immunosuppressive medications (cyclosporine, tacrolimus) — Chonluten's immunomodulatory effects may counteract immunosuppression — Use with caution—discuss with your healthcare provider.
- High-dose systemic corticosteroids — may interfere with Chonluten's bronchial epithelial differentiation mechanisms — Use with caution—discuss with your healthcare provider.
- Other potent immunostimulants at high doses without medical supervision — risk of immune overactivation in pulmonary tissue — Use with caution—discuss with your healthcare provider.
Published research
What the studies show
Avolio F, Martinotti S, Khavinson VK · 2022
Chonluten peptide and other tissue-specific peptides suppress TNF and inflammatory cytokines in immune cells, acting as natural inducers of inflammation tolerance during infections and tissue damage.
Khavinson V, Linkova N, Dyatlova A, et al. · 2020
Research (2020) on chonluten contributes important scientific knowledge about its biological and pharmacological properties.
Khavinson VKh, Tendler SM, Vanyushin BF, et al. · 2014
Research (2013) on chonluten contributes important scientific knowledge about its biological and pharmacological properties.
Khavinson VK, Popovich IG, Linkova NS, et al. · 2021
Research (2021) on chonluten contributes important scientific knowledge about its biological and pharmacological properties.
Khavinson VKh, Morozov VG · 2003
Thymic and pineal peptides (Thymalin and Epithalamin) reduced mortality in elderly patients by 2-4 fold over 6-8 years while improving cardiovascular, immune, and metabolic function.
2024
Marketed as a peptide supplement. Commonly used in practice at 1-2 capsules once or twice daily with meals; average course 10-30 days, repeated 2-3 times per year. Not approved as a medicine in Western jurisdictions.
Head to head
Chonluten compared
Want the full picture?
The complete Chonluten research profile: mechanism of action, clinical studies, effectiveness timeline, and FAQ.